Back To Search Results

Laser Principles in Ophthalmology

Editor: Koushik Tripathy Updated: 8/25/2023 3:04:42 AM

Introduction

Since its development almost 60 years ago, lasers have made a huge impact on the medical field. The laser came about after the attempts by Charles Towns and Arthur Schawlow to produce a maser (microwave amplification by stimulated emission of radiation) that had higher frequency coherent radiation at wavelengths in the visible spectrum.[1] Ophthalmology was the first medical specialty to utilize lasers, with the first report utilizing a ruby laser to treat ocular lesions almost a year after the invention of the laser, and still has the most laser procedures compared to any other specialty with the use of lasers permeating all subspecialties both diagnostically and therapeutically.[2] Therefore, understanding the principles of lasers is integral to the foundational knowledge of ophthalmologists. In this review article, we will discuss the fundamentals of lasers, the different mechanisms of lasers in ophthalmology, their therapeutic and diagnostic uses in ophthalmology, and their complications.

Laser is an acronym that stands for light amplification by stimulated emission of radiation. Electrons will emit a photon when they drop from higher energy to a lower energy level. Some of these higher energy states can be metastable, meaning they can maintain that high energy state for some time.[1] 

When a photon of a specific frequency passes by this metastable electron, it may stimulate the electron to drop to the lower energy state and radiate a photon identical to the photon that stimulated the electron.[1] Therefore, utilizing an active medium inside a resonator cavity with a fully reflective mirror on one end and a partially reflective mirror on the other can create a laser. By raising the energy levels of the medium with either an electrical or optical energy source, spontaneous decay causes the release of light, which will bounce back and forth in the cavity. The light, in turn, causes the emission of photons from the rest of the electrons that are all channeled into an intense beam that exits through the partially reflective mirror.[1] The light is monochromatic and coherent since each particle has the same wavelength and phase. It is highly directional with a high energy density as it can be focused in a small area.[3]

Lasers can be defined by their medium, which can be gas (including argon and argon fluoride), liquid (including dye), solid (including neodymium: yttrium-aluminum-garnet), or semiconductor (diode).[4] Due to the monochromatic nature of lasers, different mediums allow for lasers at specific wavelengths. Some examples are frequency-doubled neodymium: yttrium-aluminum-garnet (Nd: YAG) green laser at 532 nm, green argon lasers at 514 nm, krypton red lasers at 647 nm, and yellow semiconductor at 577 nm, diode laser at 810 nm, Nd: YAG laser at 1064 nm, and argon fluoride laser at 193 nm.

Function

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Function

Mechanisms of Lasers

The mechanisms of lasers can be separated into five types based on the power density of the laser and its exposure time with the tissue.[1] The categories are (in ascending order of power density) as follows:

  • Photochemical interaction
  • Thermal interaction
  • Photoablation
  • Plasma-induced ablation
  • Photodisruption

Photochemical interaction, otherwise known as photoactivation, is the mechanism of using long exposure times at lower power density to chemically catalyze a photosensitive dye (photocatalysis).[5] The long exposure time allows for the absorption of a large number of photons, and the low power density guarantees an insignificant rise in temperature. By utilizing a laser at the specific wavelength of the dye, a photochemical reaction occurs only in the tissue where the dye is located. 

Thermal interactions usually use shorter exposure times and higher power density levels than photochemical interactions. This allows the laser to be absorbed by tissue pigment, which causes the tissue to become hot enough to coagulate and denature.[6][7] 

The amount of heating depends on the properties of the laser and the tissue targeted, but usually, an increase of 10 to 20 degrees C is enough to cause coagulation, with the effect predominately occurring at the 60-70 C mark.[8]

Photoablation, also known as photodecomposition, allows for the splitting of molecules by breaking their covalent chemical bonds without heat transfer to nearby tissue (ultraviolet dissociation).[9] This is accomplished by using excimer lasers in the UV range that deliver around 6 electron voltage in short pulses that are a few nanoseconds in duration (short duration to avoid heat and enough energy).[10] The name 'excimer' laser is short for "excited dimer" laser as they are comprised of two gases, such as the argon fluoride excimer laser, which emits a laser of 193 nm wavelength.[10]

Plasma-induced ablation, like photoablation, breaks down molecules but also leads to plasma formation through a process called cascade ionization. Essentially, it ionizes atoms by stripping them of their electrons and speeds electrons up (optical breakdown) so that they can collide with other atoms and ionize those atoms as well (plasma ionization).[11] This is possible with infrared femtosecond lasers that are 1053 nm in wavelength by using power density up to 10^13 W/cm^2 range while using exposure times in the pico to femtosecond range (higher power density than photoablation and shorter pulse duration). The plasma formation, in turn, allows for precise and clean tissue removal with minimal thermal damage to surrounding tissue and inflammation. Unlike photoablation, UV lasers are not needed to transfer energy to transparent tissues like the cornea as the plasma created can absorb non-UV laser photons. However, there are some side effects, such as cavitation bubbles and the creation of a shock wave.[11] However, these are ultimately insignificant to the overall effect of the laser on the tissue, unlike in photodisruption, where these side effects are the main method of breaking down tissue. 

Photodisruption uses even higher energy power densities than plasma-induced ablation using pulses that are a few nanoseconds long.[12] As such, it can also induce "optical breakdown," resulting in plasma formation. The plasma then expands, producing a focal mechanical shockwave at the site, which is used to cut ocular tissue, unlike plasma-induced ablation which relies on laser light to break down tissue.[12] 

When the pulse duration is reduced, the power (energy per second) increases for a given energy. Thus, ultrashort pulses (femtosecond laser) can generate higher peak power with lower energy when compared to nanosecond pulses.

Issues of Concern

Complications

The most likely cause of complications from lasers is accidental exposure to reflected beams.[13] Lasers will be reflected by any equipment or item that is reflective in nature. For instance, many items in the surgical field are metal and will reflect the laser. Even the cornea and contact lenses are reflective. Additionally, many lasers operate in the infrared and ultraviolet ranges and are not perceptible to the human eye. Findings on examination of people with laser damage include corneal scarring, retinal hemorrhage, or in severe cases, corneal perforation.[14]

Outside of accidental exposure to reflective beams, complications of laser damage can depend on the procedure used and the type of laser used. For example, adverse effects of PRP (pan-retinal photocoagulation) include macular edema, Bruch membrane ruptures, subretinal or vitreous hemorrhage, retinal or choroidal scarring, secondary angle-closure glaucoma due to choroidal and ciliary effusion, and exudative retinal detachments.[15][16] However, lasers used in LASIK (Laser-assisted in situ keratomileuses) would have adverse effects such as flap complication, post-LASIK corneal ectasia, or corneal scarring.[17] 

Finally, another common source of laser injuries is those that pertain to laser pointers. There has been a significant increase in laser pointer-related injuries. It has been hypothesized that due to the increase in accessibility of laser pointers, even high-end lasers, over the internet. Patients have been shown to have symptoms ranging from focal photoreceptor defects to loss of visual acuity and central scotoma.[18] 

If the patient has symptoms or findings suspicious of accidental laser exposure or procedural complications, a thorough dilated ophthalmoscopy exam should be done to visualize and characterize the damage done to the eye. It may be necessary to use imaging such as OCT (optical coherence tomography), fluorescein angiography, or fundus autofluorescence to document the injury.[19][20][21] In general, there can be irreversible damage to the eye if lasers are not handled properly.

Hazard Risk

As outlined in the ANSI Z136.1, lasers can be grouped into classes based on their hazard risk. This is based on if the laser's maximum permissible emission (MPE), which determines how long an unprotected eye can be exposed to a laser before damage occurs, is shorter or longer than the human aversion response.[22]

The aversion response is the autonomic blinking and moving away of the eye from the stimulus. Lasers are placed into four classes, with the lower classes generally do not need protective eyewear because the eye can avert from the light before damage occurs, but higher classes, such as 3 and 4, require eye protection at all times.

There are several classes for lasers.[22] They are as follows:

  • Class 1: safe under all conceivable uses, 1M: safe but potentially hazardous with magnification
    • CD-ROM players, diagnostic lasers such as those used in OCT
  • Class 2: laser must emit a visible beam and are safe if viewed for less than 0.25 seconds, 2M: same as for Class 2 but not safe with optical viewing aids
    • Supermarket scanners
  • Class 3R: potentially hazardous under direct and reflective beams but does not pose either a fire hazard or diffuse-reflection hazard, 3B: hazardous under direct and reflective beams and not normally a fire hazard
    • Laser pointers
  • Class 4: laser systems whose output exceeds class 3 and are either a fire or skin hazard
    • Medical and research lasers include the double frequency Nd: YAG laser 532 nm.

Clinical Significance

Each of the five mechanisms of lasers has clear and separate clinical applications.

Thermal lasers are the most commonly used in ophthalmology, and photocoagulation is used to treat a wide array of pathology, including retinal detachments, laser barricade of retinal tears, treatment of retinopathy of prematurity and proliferative diabetic retinopathy, laser trabeculoplasty in glaucoma, focal laser in diabetic macular edema and central serous chorioretinopathy, and transpupillary thermotherapy for choroidal melanoma.[23][24][25] 

The laser's wavelength is important as absorption is heavily dependent on it. Common targets in the retina, such as hemoglobin and melanin, generally absorb wavelengths of light between 400 to 700 nm.[26][27] Additionally, lasers above 500 nm are preferred in the macula as yellow xanthophyll pigment in the macula absorbs light at wavelengths between 450 to 500 nm, and the macular damage can be avoided.[28] 

It is no surprise that common lasers used are frequency-doubled yttrium-aluminum-garnet (Nd: YAG) green laser at 532 nm, green argon lasers at 514 nm, Krypton red lasers at 647 nm, and yellow semiconductor at 577 nm and diode laser at 810 nm with the two most common being frequency-doubled Nd: YAG and argon.[1] 

Additionally, there is the PASCAL (PAtterned SCAnning Laser), which uses the frequency-doubled Nd: YAG laser that incorporates patterned, short, multiple shots at a very short duration which results in reduced discomfort and collateral retinal damage during procedures such as pan-retinal photocoagulation (PRP).[29] 

Thermal laser (photocoagulation) is also used in laser thermal keratoplasty [LTK, holmium: yttrium aluminum garnet (YAG), 2060 nm (contact LTK) or 2130 nm (noncontact LTK)], which causes corneal shrinkage to treat hyperopia.[30]

Photodisruption is another widely used laser mechanism in ophthalmology, being only second to thermal lasers. It commonly uses the Nd: YAG laser at 1064  nm in posterior capsulotomy, anterior laser vitreolysis, and peripheral laser iridotomy.[31][32][33]

Photochemical interaction is the basis of a number of techniques in ophthalmology, such as photodynamic therapy (PDT) in central serous chorioretinopathy or age-related macular degeneration (AMD), corneal collagen cross-linking in keratoconus, and prevention of graft rejection in corneal grafts by reducing corneal neovascularization.[34][5][35][36] 

In AMD, by injecting verteporfin into the patient's circulation, the blood vessels can be thrombosed by irradiating the blood vessels with the low-energy red laser at 689 nm.[37] In the case of keratoconus, riboflavin is activated using ultraviolet-A (UV-A, 365 to 370 nm) light, and in corneal neovascularization, a green argon laser is used.[38][39] For corneal photodynamic therapy for infective keratitis or corneal cross-linking with rose Bengal, a green laser (532 or 518, or 525 nm) is used.[40][41]

Photoablation is used in refractive surgeries, such as laser in situ keratomileuses (LASIK) and photorefractive keratectomy (excimer 193 nm), eliminating injury or dystrophy caused by superficial corneal opacities and in phototherapeutic keratectomy which is used in the treatment of recurrent corneal erosions as the cornea absorbs UV light under 315nm.[42][43][44]

Plasma-induced ablation has been used for refractive surgery, such as the formation of LASIK stromal flaps (femtosecond laser 1053 nm). Further research is being done into its use in other laser procedures that use photoablation.[45]

Diagnostic Use of Laser In Ophthalmology

Although lasers are used in various therapeutic techniques, they are also an integral part of diagnostic imaging in ophthalmology. For instance, scanning laser ophthalmoscopy (SLO) uses confocal laser scanning microscopy for diagnostic imaging of the retina or cornea. It uses lasers to rapidly scan a sample whose reflected light is imaged through a pinhole that suppresses reflections outside those in the focal plane.[46]

This process allows a sample to be scanned at multiple levels, which then is reconstructed in 3-dimensional images using computer software. This technique is used to track glaucoma-induced changes in the optic nerve head, along with imaging structures of the eye such as the cornea, lens, and macula. Additionally, there is optical coherence tomography (OCT) which creates high-resolution images of parts of the eye such as the retina or the anterior segment.[47] 

It typically uses either superluminescent diodes or ultrashort pulsed lasers to scan the eye and creates the image using the principles of low-coherence interferometry. OCTs are used to manage many pathologies such as glaucoma, AMD, and diabetic macular edema (DME). Finally, there is OCT angiography (OCT-A) which uses OCT to image vasculature in the eye by using the reflection of light off of moving red blood cells.[48] 

Common wavelengths for diagnostic lasers are 850-1050 nm laser in OCT, 840 nm or 1050 nm laser in OCT-A, and SLO uses a combination of lasers at 532 nm, 658 nm, and 840 nm.[49][50][51] Common laser wavelengths used in ophthalmic diagnostic machines include Optovue (RTVue) OCT (superluminescent diode, 840 nm), Cirrus OCT (superluminescent diode, 840 nm), Spectralis OCT (broadband superluminescent diode, central wavelength 880 nm, 40 nm spectral bandwidth), swept-source OCT (DRI-OCT-1, Topcon, tunable laser, median wavelength 1050 nm), IOL Master 700 (1055 nm, swept-source OCT), IOL Master 500 (partial coherence interferometry, 780 nm), and Lenstar LS-900 (optical low coherence reflectometry, superluminescent diode, 820 nm).[52][53][54]

Other Issues

Methods of Delivery

Using lasers at a slit lamp is the most commonly used method to deliver treatment since changing and controlling parameters such as power, spot size, and exposure time is easy. Another commonly used method is using an indirect ophthalmoscope via a fiber optic cable. It is commonly used to treat peripheral retinal break and retinopathy of prematurity. Finally, there is the endolaser, a small fiber-optic probe inserted into the eye for vitreoretinal surgical procedures.[55]

For focal laser of the macular lesions or leaks, the lenses used usually have a laser spot magnification factor of around 1 (including the Volk Area Centralis lens). Thus, the laser spot size at the retina is approximately 50 microns when a spot size of 50 microns is set on the laser machine. The lenses used for PRP usually have a laser spot magnification factor of 2 (including Volk Super Quad 160 and Ocular Mainster PRP 165). Thus, a laser spot set at the machine at 250 microns would yield a retinal spot of around 500 microns. Other common lenses used in Ophthalmic lasers include:

  • Abraham lens: Different lenses are available for laser (YAG) capsulotomy and laser peripheral iridotomy.
  • Singh Mid-Vitreous for treatment of symptomatic vitreous floaters, and
  • Blumenthal lens: Different lenses are available for suture lysis (usually after trabeculectomy) and laser peripheral iridotomy).

Personnel

The administration and usage of lasers require an advanced understanding of their use and safety risks. Only trained and qualified physicians should use the laser device. Additional help to improve patient comfort may require trained assistants who can help facilitate safe and effective treatment.

Preparation

Before any laser procedure, informed consent is an essential part. This includes discussing benefits, risks, and alternatives before the procedure starts. The laser device should be turned on and set to the appropriate settings for the procedure. If there are any issues with the laser, maintenance and calibrations should only be performed by a trained technician before the laser device can be operated again.[55]

Safety

Instructions and safety precautions should be reviewed when using a laser as outlined in the manual, and equipment should be inspected. A warning sign should be placed on the door to the treatment team to inform people outside that laser therapy is ongoing and should not be entered. Inside the room, any mirror or reflective hazards should be removed or moved as they could reflect the laser and cause accidental laser exposure previously discussed.

Physicians performing laser therapy should have safety filters in their devices to protect them from back-scattered light. These filters should be implemented in all slit lamps and indirect ophthalmoscopes for lasers. Operating microscopes should have a separate eye filter implemented in each viewing path of the microscope. To enable long-term viewing of the laser, these filters need to have an optical density specific to the laser wavelength used. Any personnel or bystanders must wear laser safety glasses designed to filter the specific power and wavelength of the laser.

Enhancing Healthcare Team Outcomes

Lasers are essential to ophthalmology treatment and diagnostics, but if used improperly can cause unnecessary injury. Understanding the use and mechanism of lasers is crucial for all team members associated with care. Lasers are best managed by an interprofessional team that includes an ophthalmologist trained in the specific use of that laser, nurses, and technicians, all contributing from their areas of expertise and engaging in open communication among team members, so that patient care is the top priority. Proper setup and safety precautions are important to ensuring patient and staff safety while maximizing outcomes and comfort.

References


[1]

Blumenkranz MS, The evolution of laser therapy in ophthalmology: a perspective on the interactions between photons, patients, physicians, and physicists: the LXX Edward Jackson Memorial Lecture. American journal of ophthalmology. 2014 Jul;     [PubMed PMID: 24699157]

Level 3 (low-level) evidence

[2]

Palanker D, Evolution of Concepts and Technologies in Ophthalmic Laser Therapy. Annual review of vision science. 2016 Oct 14;     [PubMed PMID: 28532364]


[3]

Moo-Young GA, Lasers in ophthalmology. The Western journal of medicine. 1985 Dec;     [PubMed PMID: 4090489]


[4]

Ferrer O,Sklar HA, A new laser for ophthalmic surgery. Developments in ophthalmology. 1987;     [PubMed PMID: 3653487]


[5]

Kwiatkowski S,Knap B,Przystupski D,Saczko J,Kędzierska E,Knap-Czop K,Kotlińska J,Michel O,Kotowski K,Kulbacka J, Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomedicine     [PubMed PMID: 30119176]


[6]

Sramek C,Paulus Y,Nomoto H,Huie P,Brown J,Palanker D, Dynamics of retinal photocoagulation and rupture. Journal of biomedical optics. 2009 May-Jun;     [PubMed PMID: 19566300]

Level 3 (low-level) evidence

[7]

Mainster MA, Decreasing retinal photocoagulation damage: principles and techniques. Seminars in ophthalmology. 1999 Dec;     [PubMed PMID: 10758220]


[8]

Lock JH,Fong KC, Retinal laser photocoagulation. The Medical journal of Malaysia. 2010 Mar     [PubMed PMID: 21265262]


[9]

Vogel A,Venugopalan V, Mechanisms of pulsed laser ablation of biological tissues. Chemical reviews. 2003 Feb;     [PubMed PMID: 12580643]

Level 3 (low-level) evidence

[10]

Manche EE,Carr JD,Haw WW,Hersh PS, Excimer laser refractive surgery. The Western journal of medicine. 1998 Jul;     [PubMed PMID: 9682628]


[11]

Tsai PS,Blinder P,Migliori BJ,Neev J,Jin Y,Squier JA,Kleinfeld D, Plasma-mediated ablation: an optical tool for submicrometer surgery on neuronal and vascular systems. Current opinion in biotechnology. 2009 Feb;     [PubMed PMID: 19269159]

Level 3 (low-level) evidence

[12]

Vogel A,Busch S,Jungnickel K,Birngruber R, Mechanisms of intraocular photodisruption with picosecond and nanosecond laser pulses. Lasers in surgery and medicine. 1994;     [PubMed PMID: 7997046]


[13]

Sliney DH, Laser safety. Lasers in surgery and medicine. 1995;     [PubMed PMID: 7791495]


[14]

Barkana Y,Belkin M, Laser eye injuries. Survey of ophthalmology. 2000 May-Jun;     [PubMed PMID: 10906379]

Level 3 (low-level) evidence

[15]

Shukla UV, Tripathy K. Diabetic Retinopathy. StatPearls. 2024 Jan:():     [PubMed PMID: 32809640]


[16]

Reddy SV,Husain D, Panretinal Photocoagulation: A Review of Complications. Seminars in ophthalmology. 2018;     [PubMed PMID: 29172937]


[17]

Gierek-Ciaciura S, [Complications after LASIK surgery]. Klinika oczna. 2002;     [PubMed PMID: 12664494]


[18]

Birtel J,Harmening WM,Krohne TU,Holz FG,Charbel Issa P,Herrmann P, Retinal Injury Following Laser Pointer Exposure. Deutsches Arzteblatt international. 2017 Dec 8     [PubMed PMID: 29271340]


[19]

Ruia S, Tripathy K. Fluorescein Angiography. StatPearls. 2024 Jan:():     [PubMed PMID: 35015403]


[20]

Mainster MA,Stuck BE,Brown J Jr, Assessment of alleged retinal laser injuries. Archives of ophthalmology (Chicago, Ill. : 1960). 2004 Aug;     [PubMed PMID: 15302664]

Level 3 (low-level) evidence

[21]

Commiskey PW,Heisel CJ,Paulus YM, Non-Therapeutic Laser Retinal Injury. International journal of ophthalmic research. 2019;     [PubMed PMID: 32923732]


[22]

Smalley PJ. Laser safety: Risks, hazards, and control measures. Laser therapy. 2011:20(2):95-106     [PubMed PMID: 24155518]


[23]

Velieva IA,Surnina ZV, [Indications for retinal laser coagulation in the treatment of retinoschisis and rhegmatogenous retinal detachment]. Vestnik oftalmologii. 2020;     [PubMed PMID: 33084279]


[24]

Lightman S,Towler HM, Diabetic retinopathy. Clinical cornerstone. 2003;     [PubMed PMID: 12800477]


[25]

Wong TY,Scott IU, Clinical practice. Retinal-vein occlusion. The New England journal of medicine. 2010 Nov 25;     [PubMed PMID: 21105795]


[26]

Ma A,Yu SWY,Wong JKW, Micropulse laser for the treatment of glaucoma: A literature review. Survey of ophthalmology. 2019 Jul - Aug;     [PubMed PMID: 30639207]

Level 3 (low-level) evidence

[27]

Zonios G,Dimou A, Melanin optical properties provide evidence for chemical and structural disorder in vivo. Optics express. 2008 May 26;     [PubMed PMID: 18545538]

Level 3 (low-level) evidence

[28]

Peyman GA,Raichand M,Zeimer RC, Ocular effects of various laser wavelengths. Survey of ophthalmology. 1984 Mar-Apr;     [PubMed PMID: 6426070]

Level 3 (low-level) evidence

[29]

Salman AG, Pascal laser versus conventional laser for treatment of diabetic retinopathy. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. 2011 Apr;     [PubMed PMID: 23960919]


[30]

Majumdar S, Tripathy K. Hyperopia. StatPearls. 2023 Jan:():     [PubMed PMID: 32809551]


[31]

Karahan E,Er D,Kaynak S, An Overview of Nd:YAG Laser Capsulotomy. Medical hypothesis, discovery     [PubMed PMID: 25738159]

Level 3 (low-level) evidence

[32]

Levy JH,Pisacano AM, Clinical experience with Nd:YAG laser vitreolysis in the anterior segment. Journal of cataract and refractive surgery. 1987 Sep;     [PubMed PMID: 3668839]


[33]

Drake MV, Neodymium:YAG laser iridotomy. Survey of ophthalmology. 1987 Nov-Dec;     [PubMed PMID: 3328316]

Level 3 (low-level) evidence

[34]

Gupta A, Tripathy K. Central Serous Chorioretinopathy. StatPearls. 2024 Jan:():     [PubMed PMID: 32644399]


[35]

Saad S,Saad R,Jouve L,Kallel S,Trinh L,Goemaere I,Borderie V,Bouheraoua N, Corneal crosslinking in keratoconus management. Journal francais d'ophtalmologie. 2020 Dec;     [PubMed PMID: 32972759]


[36]

Yoon KC,You IC,Kang IS,Im SK,Ahn JK,Park YG,Ahn KY, Photodynamic therapy with verteporfin for corneal neovascularization. American journal of ophthalmology. 2007 Sep;     [PubMed PMID: 17631268]


[37]

Nowak JZ, Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacological reports : PR. 2006 May-Jun;     [PubMed PMID: 16845209]


[38]

Wollensak G,Spoerl E,Seiler T, Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. American journal of ophthalmology. 2003 May;     [PubMed PMID: 12719068]

Level 3 (low-level) evidence

[39]

Sheppard JD Jr,Epstein RJ,Lattanzio FA Jr,Marcantonio D,Williams PB, Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether. American journal of ophthalmology. 2006 Mar;     [PubMed PMID: 16490500]


[40]

Hung JH,Lee CN,Hsu HW,Ng IS,Wu CJ,Yu CK,Lee NY,Chang Y,Wong TW, Recent Advances in Photodynamic Therapy against Fungal Keratitis. Pharmaceutics. 2021 Nov 26     [PubMed PMID: 34959293]

Level 3 (low-level) evidence

[41]

Martinez JD,Arrieta E,Naranjo A,Monsalve P,Mintz KJ,Peterson J,Arboleda A,Durkee H,Aguilar MC,Pelaez D,Dubovy SR,Miller D,Leblanc R,Amescua G,Parel JM, Rose Bengal Photodynamic Antimicrobial Therapy: A Pilot Safety Study. Cornea. 2021 Aug 1;     [PubMed PMID: 34190718]

Level 3 (low-level) evidence

[42]

Pidro A,Biscevic A,Pjano MA,Mravicic I,Bejdic N,Bohac M, Excimer Lasers in Refractive Surgery. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia     [PubMed PMID: 32055096]


[43]

Ambrósio R Jr,Wilson S, LASIK vs LASEK vs PRK: advantages and indications. Seminars in ophthalmology. 2003 Mar;     [PubMed PMID: 12759854]


[44]

Ayres BD,Rapuano CJ, Excimer laser phototherapeutic keratectomy. The ocular surface. 2006 Oct;     [PubMed PMID: 17146575]


[45]

Bashir ZS,Ali MH,Anwar A,Ayub MH,Butt NH, Femto-lasik: The recent innovation in laser assisted refractive surgery. JPMA. The Journal of the Pakistan Medical Association. 2017 Apr;     [PubMed PMID: 28420926]


[46]

Paddock SW,Eliceiri KW, Laser scanning confocal microscopy: history, applications, and related optical sectioning techniques. Methods in molecular biology (Clifton, N.J.). 2014;     [PubMed PMID: 24052346]


[47]

Sander B, Optical coherence tomography in ophthalmology: an overview. Acta ophthalmologica. 2009 May;     [PubMed PMID: 18976317]

Level 3 (low-level) evidence

[48]

de Carlo TE,Romano A,Waheed NK,Duker JS, A review of optical coherence tomography angiography (OCTA). International journal of retina and vitreous. 2015;     [PubMed PMID: 27847598]


[49]

Adhi M, Duker JS. Optical coherence tomography--current and future applications. Current opinion in ophthalmology. 2013 May:24(3):213-21. doi: 10.1097/ICU.0b013e32835f8bf8. Epub     [PubMed PMID: 23429598]

Level 3 (low-level) evidence

[50]

Pichi F,Sarraf D,Arepalli S,Lowder CY,Cunningham ET Jr,Neri P,Albini TA,Gupta V,Baynes K,Srivastava SK, The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Progress in retinal and eye research. 2017 Jul     [PubMed PMID: 28465249]


[51]

Grieve K,Tiruveedhula P,Zhang Y,Roorda A, Multi-wavelength imaging with the adaptive optics scanning laser Ophthalmoscope. Optics express. 2006 Dec 11     [PubMed PMID: 19529652]


[52]

Lavinsky F,Lavinsky D, Novel perspectives on swept-source optical coherence tomography. International journal of retina and vitreous. 2016;     [PubMed PMID: 27847643]

Level 3 (low-level) evidence

[53]

Bille JF, Aumann S, Donner S, Fischer J, Müller F. Optical Coherence Tomography (OCT): Principle and Technical Realization. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics. 2019:():     [PubMed PMID: 32091846]


[54]

Gao R,Chen H,Savini G,Miao Y,Wang X,Yang J,Zhao W,Wang Q,Huang J, Comparison of ocular biometric measurements between a new swept-source optical coherence tomography and a common optical low coherence reflectometry. Scientific reports. 2017 May 30     [PubMed PMID: 28559547]


[55]

Cordero I, Understanding and safely using ophthalmic lasers. Community eye health. 2015;     [PubMed PMID: 27418730]

Level 3 (low-level) evidence